Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Bristol-Myers Squibb Pharmaceuticals Unlimited Company, Plaza 254, Blanchardstown Corporate Park 2, Dublin 15, Dublin, D15 T867
Adcortyl Intra-articular/Intradermal Injection 10 mg/ml.
| Pharmaceutical Form |
|---|
|
Sterile aqueous suspension for injection. |
Adcortyl Intra-articular/Intradermal Injection contains triamcinolone acetonide 10 mg per ml of sterile suspension.
Excipient(s) with known effect: 15 mg/ml Benzyl alcohol.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Triamcinolone |
Triamcinolone acetonide is a more potent derivative of triamcinolone and is approximately 8 times more potent than prednisone. Although the precise mechanism of corticosteroid anti-allergic action is unknown, corticosteroids are very effective in the treatment of allergic diseases in man. Also, local injections are thought to have an anti-inflammatory effect. |
| List of Excipients |
|---|
|
Benzyl alcohol |
Carton containing glass ampoules 5 × 1 ml or individually cartoned multidose vials of 5 ml.
Bristol-Myers Squibb Pharmaceuticals Unlimited Company, Plaza 254, Blanchardstown Corporate Park 2, Dublin 15, Dublin, D15 T867
PL 12038/0001
Date of first authorisation: 25 July 1986
Date of latest renewal: 8 November 2002
| Drug | Countries | |
|---|---|---|
| ADCORTYL | Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
